Keywords: spp635, successful, hypertension, study, switzerland-based, drug, developer

SPP635 successful in hypertension study

Article | 09 July 2007

Print This

Switzerland-based drug developer Speedel says it has achieved another milestone in its development of the renin inhibitor SPP635 as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in